The Essential Guide: What is Clinical Research?
Clinical research is the engine behind modern medicine. Without this rigorous process, we would have no way of knowing if a drug is a miracle cure or a dangerous risk.
Scientific Definition
Clinical research is a branch of healthcare science that determines the safety and effectiveness (efficacy) of medications, devices, and diagnostic products intended for human use.
The Phases of Discovery
Phase I: Safety & Dosage
Conducted on small groups (20-100) of healthy volunteers to determine side effects and the safe dosage range.
Phase II: Efficacy
Conducted on larger groups (100-300) with the target disease to see if the drug actually works as intended.
Phase III: Confirmation
Conducted on thousands of patients to confirm efficacy, monitor side effects, and compare it to existing standard treatments.
Protections & Ethics
Every trial must be reviewed by an Institutional Review Board (IRB) to ensure that the rights and welfare of human subjects are protected throughout the investigative process.
Why Clinical Research Is the Foundation of Modern Medicine
Every medication in your medicine cabinet, every device implanted in a patient's chest, and every vaccine that has controlled or eliminated disease — all of it passed through the clinical research process before reaching the public. Without this structured scientific method, we would have no reliable way to distinguish treatments that work from those that merely seem to work.
The U.S. alone spends over $80 billion annually on clinical research, and the global pharmaceutical industry invests an estimated $240 billion per year in research and development. These staggering numbers exist because the alternative — approving drugs without rigorous evidence — carries consequences too severe to accept.
The Two Main Types of Clinical Research
Not all clinical research involves testing a new drug. In fact, the field divides broadly into two major categories that serve different purposes:
Interventional Studies
The researcher introduces a change — a drug, device, procedure, or behavioral intervention — and measures the effect on participants. This is what most people picture when they think of a "clinical trial."
Examples: Drug trials, surgical technique comparisons, vaccine studies, medical device testing
Observational Studies
Researchers observe participants without introducing any intervention. They collect and analyze data about natural behaviors, exposures, or outcomes to identify patterns and associations.
Examples: Epidemiological studies, registries, longitudinal cohort studies, case-control studies
A Deeper Look at the Four Trial Phases
The phased approach to drug development exists because it's the most responsible way to build evidence while protecting participants. Each phase answers different questions, involves more participants, and carries different risk profiles.
Phase I: First-in-Human Safety
20–100 ParticipantsPhase I trials are typically the first time a new drug is tested in humans. Participants are usually healthy volunteers (though oncology trials often use patients). The primary goal is to determine the drug's safety profile, how it's processed by the body (pharmacokinetics), and to identify the maximum tolerated dose.
Key questions: Is it safe? How does the body absorb and eliminate it? What dose is tolerable?
Phase II: Early Efficacy Testing
100–300 ParticipantsPhase II expands to larger groups of patients who actually have the condition being studied. The focus shifts from pure safety to evidence of efficacy — does the drug actually produce a measurable therapeutic effect? Side effects continue to be closely monitored, and the optimal dosing regimen is refined.
Key questions: Does it work? What is the optimal dose and dosing schedule?
Phase III: Confirmatory Large-Scale Trial
1,000–10,000+ ParticipantsPhase III is the pivotal study. Large, often randomized and blinded trials compare the new drug against a placebo or existing standard of care. Statistical power is critical — these trials generate the evidence base that regulators use to make approval decisions. Passing Phase III and submitting an NDA or BLA is the gateway to market.
Key questions: Is it more effective than current treatment? What is the full safety and side effect profile at scale?
Phase IV: Post-Market Surveillance
Thousands of PatientsPhase IV studies occur after a drug has received regulatory approval and is available to the public. These "post-marketing studies" monitor long-term effects, track rare adverse events that only emerge in very large populations, and may explore additional uses (new indications) for the approved drug.
Key questions: Are there long-term risks? Do rare side effects appear at population scale? Can it treat other conditions?
The Regulatory Approval Pathway
Before a company can even begin testing a drug in humans, they must submit an Investigational New Drug (IND) application to the FDA. This application details the drug's composition, manufacturing process, preclinical test results, and proposed clinical protocols. Only after the FDA reviews and approves the IND can human testing begin.
Once Phase III data is collected, the sponsor submits a New Drug Application (NDA) for small molecules or a Biologics License Application (BLA) for biologics. FDA reviewers then evaluate the complete evidence package — often taking 10–12 months — before granting approval, requesting additional data, or rejecting the application.
By the Numbers: Drug Development Timeline
Protecting Participants: IRBs, GCP, and Ethical Oversight
Modern clinical research operates within a robust ethical and regulatory framework designed to prevent the abuses that occurred in historical research scandals. Every clinical trial must navigate multiple layers of oversight before a single participant can be enrolled.
Institutional Review Boards (IRBs) — also called Ethics Committees outside the U.S. — are independent bodies that review research protocols before they can begin. Their mandate is to ensure that the rights and welfare of human subjects are protected, that risks are minimized and justified by potential benefits, and that the informed consent process is appropriate.
Good Clinical Practice (GCP), as codified in ICH E6(R3), is the international quality standard that governs how clinical trials are designed, conducted, recorded, and reported. Adherence to GCP ensures that trial data is credible and that participant rights are protected. Every member of a research site team — including CRCs, PIs, and study nurses — is expected to follow GCP principles.
Historical Context: Why These Protections Exist
The current ethical framework in clinical research was shaped by documented abuses in the 20th century, including the Tuskegee Syphilis Study and unethical experimentation during World War II. The Belmont Report (1979) established the foundational principles of respect for persons, beneficence, and justice that continue to guide research ethics today. Understanding this history is essential for every clinical research professional.
The Role of the CRC in the Clinical Trial System
Clinical Research Coordinators are the operational backbone of the clinical trial site. While the Principal Investigator (PI) holds ultimate medical and regulatory responsibility for the trial, it is the CRC who manages the day-to-day logistics that keep the trial running: scheduling visits, obtaining informed consent, administering study procedures, collecting data, and maintaining the regulatory binder.
If you're considering a career in this field, understanding the broader research ecosystem described in this guide gives you the context to perform your role with greater competence and purpose. To take the next step, explore our guide to becoming a clinical researcher and our entry-level roadmap for landing your first role.
Continue Learning on The CRC Toolkit
A seasoned CRC and site management professional with over a decade of experience across Phase I–IV trials at academic medical centers and private research sites. Founder of The CRC Toolkit and an advocate for empowering site-level research staff with practical, accessible tools and education.
Citations & Regulatory Compliance
This guide is built upon standardized clinical definitions and regulatory frameworks established by global health authorities.
- • NIH (National Institutes of Health): Definition of Clinical Research and the distinction between observational and interventional studies.
- • FDA (U.S. Food and Drug Administration): Structural requirements for Phase I-IV clinical trials and the NDA/BLA approval pathway.
- • WMA Declaration of Helsinki: Ethical principles for medical research involving human subjects.
- • ICH GCP (E6 R2/R3): International standards for the conduct, recording, and reporting of trials.
Ready to start a career in this field?
Learn the technical mastery required to manage a research site in our CRC blueprint guide.
Next: CRC Site Operations Blueprint